pharmaceutical acquisitions

Research lab
Aug 11, 2026

Amneal closes $1.1B Kashiv Biosciences acquisition

The combination of Bridgewater-based Amneal Pharmaceuticals and Kashiv Biosciences from Piscataway creates a global leader in biosimilars ahead of a looming Loss of Exclusivity set to hit the market.

Laboratory
Jul 6, 2026

Novartis to acquire Myricx Bio in $1.5B cancer deal

Novartis will acquire Myricx Bio for up to $1.5B, expanding its antibody-drug conjugate pipeline for cancer treatments.